NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivoTadepally Lakshmikanth, Francesco Colucci, Marusca Capanni et al.|Journal of Clinical Investigation|2009Cited by 331
Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2Hai Li, Galina Selivanova, Tadepally Lakshmikanth et al.|Cell Cycle|2011Cited by 118
New views on natural killer cell-based immunotherapy for melanoma treatmentShannon Burke, Ennio Carbone, Francesco Colucci et al.|Trends in Immunology|2010Cited by 92
HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitorsRosa Sottile, Ennio Carbone|European Journal of Immunology|2015Cited by 37